Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Atara Biotherap (ATRA)

Atara Biotherap (ATRA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 866,005
  • Shares Outstanding, K 58,952
  • Annual Sales, $ 0 K
  • Annual Income, $ -290,980 K
  • 60-Month Beta 2.35
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.57

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -1.25
  • Number of Estimates 6
  • High Estimate -1.08
  • Low Estimate -1.48
  • Prior Year -1.60
  • Growth Rate Est. (year over year) +21.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.90 +65.06%
on 06/12/20
16.00 -8.19%
on 07/06/20
+4.78 (+48.23%)
since 06/10/20
3-Month
7.45 +97.18%
on 05/01/20
19.36 -24.12%
on 05/22/20
+6.14 (+71.81%)
since 04/09/20
52-Week
4.52 +225.00%
on 03/18/20
19.36 -24.12%
on 05/22/20
-3.60 (-19.68%)
since 07/10/19

Most Recent Stories

More News
Will Atara Biotherapeutics Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor of Atara Biotherapeutics

ATRA : 14.69 (-4.05%)
Atara Biotherapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional Shares

Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with severe diseases including...

ATRA : 14.69 (-4.05%)
Is Atara Biotherapeutics (ATRA) Stock a Solid Choice Right Now?

Atara Biotherapeutics (ATRA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

ATRA : 14.69 (-4.05%)
Atara Biotherape Set to Possibly Pullback After Yesterday's Rally of 4.17%

Atara Biotherape (NASDAQ:ATRA) traded in a range yesterday that spanned from a low of $10.53 to a high of $11.35. Yesterday, the shares gained 4.2%, which took the trading range above the 3-day high...

ATRA : 14.69 (-4.05%)
Atara Biotherapeutics Announces First Patient Enrolled in Randomized Placebo-Controlled Study of Allogeneic T-cell Therapy ATA188 in Progressive Forms of Multiple Sclerosis

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop treatments for patients with severe diseases including solid...

ATRA : 14.69 (-4.05%)
Atara Biotherape Shares Down 12.2% Since SmarTrend's Sell Call (ATRA)

SmarTrend identified a Downtrend for Atara Biotherape (NASDAQ:ATRA) on May 27th, 2020 at $11.33. In approximately 3 weeks, Atara Biotherape has returned 12.18% as of today's recent price of $9.95.

ATRA : 14.69 (-4.05%)
Atara Biotherape Rises 5.19% on Heavy Volume: Watch For Potential Pullback

Atara Biotherape (NASDAQ:ATRA) traded in a range yesterday that spanned from a low of $10.10 to a high of $10.88. Yesterday, the shares gained 5.2%, which took the trading range above the 3-day high...

ATRA : 14.69 (-4.05%)
Atara Biotherapeutics Announces its 2020 Annual Meeting of Stockholders Will Be Held on June 16, 2020 in Virtual Format

Atara Biotherapeutics, Inc. (Nasdaq: ATRA) today announced that, due to public health and safety concerns related to the coronavirus ("COVID-19") pandemic, recommendations and orders from federal, state...

ATRA : 14.69 (-4.05%)
Atara Biotherapeutics to Participate at Two Upcoming Conferences

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop treatments for patients with severe diseases including solid...

ATRA : 14.69 (-4.05%)
Atara Biotherapeutics Announces Pricing of $175.5 Million Public Offering

Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with severe diseases including...

ATRA : 14.69 (-4.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade ATRA with:

Business Summary

Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. The company's lead programs are focused on myostatin and activin, members of the TGF-beta...

See More

Key Turning Points

2nd Resistance Point 16.13
1st Resistance Point 15.41
Last Price 14.69
1st Support Level 14.22
2nd Support Level 13.75

See More

52-Week High 19.36
Last Price 14.69
Fibonacci 61.8% 13.69
Fibonacci 50% 11.94
Fibonacci 38.2% 10.19
52-Week Low 4.52

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar